Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells.
- Resource Type
- Article
- Source
- Cancers; Aug2023, Vol. 15 Issue 16, p4128, 22p
- Subject
IN vivo studies OVARIAN tumors PROGRAMMED death-ligand 1 CANCER chemotherapy METASTASIS ASCITES PLATINUM METHYLATION RESEARCH funding EPIGENOMICS IMMUNOTHERAPY ONCOLOGY - Language
- ISSN
- 20726694